Venetoclax Combined With Azacitidine and CAG in Refractory/Relapse Acute Myeloid Leukemia

NCT05807347 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Refractory/Relapse Acute Myeloid Leukemia

Interventions

DRUG: Venetoclax

Sponsor

Hematology department of the 920th hospital